28 years of biopharma R&D experience (including nearly 20 years at MSD)
Fellow of the American Statistical Association (ASA) and Scholar of Center for Innovative Study Design at Stanford University
Co-chair for the ASA real-world scientific working group (2022 – 2024)
Editorial board for the Journal of Biopharmaceutical Statistics and Contemporary Clinical Trials
MS in Physiology, Peking University.
Over ten years of industry experience. Worked in IQVIA, Novartis and other global pharmaceutical companies, CROs and start-up biotech companies, with rich experience in project management and clinical operations. Successfully conducted phase I to III clinical trials in China and multi-countries/regions, including APAC, the Middle East, North America, Eastern Europe throughout from IND to NDA.
Doctor of Biostatistics and Epidemiology, University of Tokyo.
Over 20 years of experience in statistical support for drug development and nearly 10 years of experience in managing statistical teams. Worked for Pfizer and Hengrui and successfully supported the marketing of 10+ products for 20+ indications. With extensive experience in the full life cycle of oncology and non-oncology drug development.
Major of Pharmacy, China Pharmaceutical University; MBA of Fudan university.
9 years related experience in clinical trials, TOP 10 years working experience in MNC;Promoting on the basis of IRC assess clinical efficacy and safety of the project the expansion of the solution and fall to the ground, and new technologies, such as AI research platform construction and commercialization.
Bachelor of Pharmacy, Wenzhou Medical University; MBA, Zhejiang University.
15 years of experience in business and market development in the pharmaceutical industry, and more than 10 years of experience in team and client management. Worked for pharmaceutical companies such as Pfizer, Bayer and Biotech Pharma, as well as Taimei Technology, and served as the head of the business development center of B2B and Imaging Science successively.
Bachelor's degree, Shanghai Jiao Tong University; MBA, Business School Netherlands.
Nearly 13 years of industry experience, has worked in IQVIA, FMD and pharmas, has been responsible for ClinOps team management, project oversight and KA management. Jeff has participated in multiple clinical trials of new drugs and successfully passed the NMPA inspection.